ERBB2 and neoplasm: This confirmed the remarkable anti-cancer activity of GEM@PLGA@HM, attributed to its HER2 antibody-directed tumor targeting, enhanced accumulation at HER2+ tumor sites, and the biomimetic advantage of macrophage membrane camouflaging.